11 results
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Infections of the Skin ... #IDSA #Treatment ... #management #antibiotics ... #pharmacology
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... #Meningitis #Antibiotics ... Antimicrobials #Empiric #Coverage ... InfectiousDiseases #Pharmacology ... #Management
IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections
 • Impetigo (Staphylococcus
IDSA - Antimicrobial ... Streptococcal Skin ... Streptococcal #Antibiotics ... #management #treatment ... #idsa #cellulitis
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Parenteral #IV #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... out of favor for treatment ... Anaerobic #Bacteria #Pharmacology ... Susceptibility #Coverage ... #Management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... drainage plus oral antibiotics ... have failed oral antibiotic ... treatment or those
For my UME micro course, I made a figure that captures this terminology and lets learners
‘broaden’ this coverage ... I’ve drawn the broad ... holes” in their coverage ... #pharmacology # ... management #spectrum
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
Osteomyelitis #Oral #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa